Inventor · disambiguated record
Yao Liu
Also filed as: LIU YAO · Liu yao-bin
12 granted patents·16 pending applications·66 citations·filing 2016–2025
86Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD8DANA FARBER CANCER INST INC6SHAANXI INST OF MICROBIOLOGY3UNIV JIANGNAN3PTC THERAPEUTICS INC2
Top patents by PatentIndex Score
28 records- 0196US9771424B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 26, 2017·30 cites·20 claims
- 0296US9738718B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 22, 2017·33 cites·20 claims
- 0384US11130811B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Sep 28, 2021·1 cites·18 claims
- 0482US11396559B2Amylopectin-based cyclic glucan and method for processing the sameUNIV JIANGNAN·Filed 2020·Granted Jul 26, 2022·1 cites·13 claims
- 0577US2022064299A1Icos binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0676US10351627B2ICOS binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 16, 2019·1 cites·22 claims
- 0771US2020140551A1Icos binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 0870US2025002966A1Aureobasidium pullulans p1 and method for preparing rare ginsenosideSHAANXI INST OF MICROBIOLOGY·Filed 2024·Application pending·0 cites
- 0969US2025027119A1Loctobacillus plantarum 121-5 and application thereof in preparing resveratrol by converting polydatinSHAANXI INST OF MICROBIOLOGY·Filed 2024·Application pending·0 cites
- 1065US2018334503A1Icos binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1164US12336546B2Antibacterial glucose-based composite nanoparticle and processing method and use thereofUNIV JIANGNAN·Filed 2022·Granted Jun 24, 2025·0 cites·8 claims
- 1262US2017313777A1Icos binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1361US2024050577A1Cdk inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 1459US2025207133A1Constructs, viral vectors and pharmaceutical compositions comprising long noncoding rna anril for treatment of diseaseTUFTS COLLEGE·Filed 2024·Application pending·0 cites
- 1558US2024059712A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 1657US2025179078A1Inhibitors of nlrp3PTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1755US11771697B2Small molecule degraders of polybromo-1 (PBRM1)DANA FARBER CANCER INST INC·Filed 2019·Granted Oct 3, 2023·0 cites·8 claims
- 1855US2024262806A1Inhibitors of nlrp3PTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1953US11345785B2Processing method for intelligent hydrogel from nanometer starch particlesUNIV JIANGNAN·Filed 2019·Granted May 31, 2022·0 cites·10 claims
- 2050US2024408216A1Protein inhibitor or degrading agent, pharmaceutical composition containing same and pharmaceutical useJING MEDICINE TECH SHANGHAI LTD·Filed 2022·Application pending·0 cites
- 2148US12415816B2Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Sep 16, 2025·0 cites·16 claims
- 2247US12509455B2Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 30, 2025·0 cites·18 claims
- 2347US2022073512A1Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2447US2024360132A9Tricyclic kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 2546US12421313B2Combined pharmaceutical composition for treating tumorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Sep 23, 2025·0 cites·20 claims
- 2646US2022402869A1Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2745US2025154544A1Bacillus mojavensis h12 and application thereof in frementation production of low-molecular-weight pullulanSHAANXI INST OF MICROBIOLOGY·Filed 2025·Application pending·0 cites
- 2840US12320810B2Creatine kinase isoenzyme assay kitBEIJING STRONG BIOTECHNOLOGIES INC·Filed 2019·Granted Jun 3, 2025·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →